Physician profile
Brandon Scott Davis
NPI 1285605121
$1,023.99
in general payments reported to CMS, 2019-2025
18 companies · $262 in 2025
The $262 reported for 2025 was more than what 81% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $70.90 · 2021: $26.67 · 2022: $94.32 · 2023: $196 · 2024: $202 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $151.23 | 2019-2024 | |
| Abiomed | $122.18 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $105.40 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $91.98 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $87.55 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $69.27 | 2023-2024 | |
| Recor Medical INC | $58.42 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.56 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $46.20 | 2019-2022 | |
| Abbott Laboratories | $44.40 | 2023-2025 | Freestyle Libre 3, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $43.28 | 2019-2022 | |
| Melinta Therapeutics, LLC | $37.22 | 2019 | |
| Daiichi Sankyo INC. | $25.90 | 2022 | |
| Atricure, INC. | $21.99 | 2024 | |
| Shionogi INC | $21.41 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.14 | 2025 | Collagenase Santyl |
| Otsuka America Pharmaceutical, INC. | $13.11 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.